CAMERA, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 823
NA - Nord America 703
AS - Asia 673
SA - Sud America 124
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 39
OC - Oceania 2
AN - Antartide 1
Totale 2.405
Nazione #
US - Stati Uniti d'America 670
RU - Federazione Russa 427
SG - Singapore 292
IT - Italia 176
BR - Brasile 98
VN - Vietnam 94
CN - Cina 76
HK - Hong Kong 69
GB - Regno Unito 45
BD - Bangladesh 40
DE - Germania 38
FI - Finlandia 34
TR - Turchia 21
FR - Francia 19
CA - Canada 17
IN - India 17
NL - Olanda 15
AT - Austria 12
KR - Corea 11
IE - Irlanda 10
JP - Giappone 10
PL - Polonia 10
BJ - Benin 9
MX - Messico 9
SE - Svezia 9
AR - Argentina 7
CO - Colombia 7
ES - Italia 7
ID - Indonesia 7
IQ - Iraq 7
TG - Togo 7
ZA - Sudafrica 7
PH - Filippine 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
NG - Nigeria 4
CL - Cile 3
EG - Egitto 3
MA - Marocco 3
AU - Australia 2
BE - Belgio 2
CZ - Repubblica Ceca 2
IR - Iran 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
SN - Senegal 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
ET - Etiopia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PK - Pakistan 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.367
Città #
Moscow 161
Ashburn 145
Singapore 142
San Jose 114
Hong Kong 68
Dallas 59
Verona 46
Council Bluffs 42
Ho Chi Minh City 34
New York 26
Beijing 24
Los Angeles 24
Munich 19
Hanoi 17
Helsinki 16
Istanbul 16
São Paulo 15
Milan 14
London 13
Santa Clara 13
Phoenix 12
Montreal 10
Orem 10
The Dalles 10
Amsterdam 9
Buffalo 9
Cotonou 9
Tokyo 9
Turku 9
Chandler 8
Chicago 8
Dublin 8
Lappeenranta 8
Warsaw 8
Frankfurt am Main 7
Lomé 7
Redondo Beach 7
Rome 7
Chirignago 6
Farnborough 6
Jakarta 6
Johannesburg 6
Modena 6
Nuremberg 6
Naples 5
Poplar 5
Vienna 5
Abuja 4
Baghdad 4
Bologna 4
Brooklyn 4
Chennai 4
Da Nang 4
Mexico City 4
Sommacampagna 4
Stockholm 4
Ankara 3
Boardman 3
Des Moines 3
Genoa 3
Haiphong 3
Kyiv 3
Paris 3
Popayán 3
Rio de Janeiro 3
Roverbella 3
Seattle 3
Springfield 3
Thái Bình 3
Treviso 3
Vicenza 3
Allen 2
Atlanta 2
Azzano San Paolo 2
Barnet 2
Belo Horizonte 2
Bengaluru 2
Boston 2
Brasília 2
Bình Dương 2
Can Tho 2
Canelinha 2
Castelfranco Veneto 2
Dakar 2
Denver 2
Diadema 2
Fort Worth 2
Fortaleza 2
Goiânia 2
Gramado 2
Guarulhos 2
Guayaquil 2
Ha Long 2
Helena 2
Houston 2
Hyderabad 2
Itabira 2
Joinville 2
Kathmandu 2
Kingston 2
Totale 1.353
Nome #
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands 166
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 161
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 156
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 154
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 150
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 144
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 134
Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of Progress 132
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course 131
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 130
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 120
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 115
Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease 112
Sleep-related hypermotor epilepsy in a patient with myelin-oligodendrocyte-glycoprotein antibody disease 107
Factors influencing longitudinal MRI structural and cognitive measures in MOGAD and MS 94
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease 85
Predictors of relapse and disability in NMOSD, MOGAD, and double-seronegative demyelinating syndromes: an international multicenter retrospective cohort study 73
Unsupervised Clustering Based on Quantitative Magnetic Resonance Imaging Features Contributes to the Characterization of MS White Matter Lesions 47
Choroid plexus volume predicts progression independent of relapse activity in early relapsing multiple sclerosis 42
Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosis 38
Quantitative Magnetic resonance imaging lesion features allow machine learning-based classification of MS patients with Progression Independent of Relapse Activity 37
The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosis 30
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes 21
Paramagnetic Rim Lesions and Choroid Plexus Volume at Diagnosis Are Associated With Cognitive Progression Independent of Relapse and MRI Activity in Early Relapsing-Remitting Multiple Sclerosis 12
Failed, Inconclusive or Interrupted Trials in Multiple Sclerosis: 2020-2024 Update 10
Investigating the Presence of Neurodegeneration Independent of Relapses in MOGAD Compared to Relapsing-Remitting Multiple Sclerosis 4
Totale 2.405
Categoria #
all - tutte 8.988
article - articoli 7.661
book - libri 0
conference - conferenze 1.327
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 0 0 0 0 0 0 0 0 6 1 1
2022/202327 1 3 1 5 1 6 0 1 2 0 6 1
2023/202469 1 3 3 6 7 11 14 2 2 6 10 4
2024/2025464 8 24 20 72 9 13 23 28 64 56 51 96
2025/20261.737 74 86 81 306 434 77 175 100 149 111 68 76
2026/2027100 56 44 0 0 0 0 0 0 0 0 0 0
Totale 2.405